nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—CYP2C8—Mometasone—systemic scleroderma	0.0815	0.139	CbGbCtD
Nifedipine—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.0674	0.115	CbGbCtD
Nifedipine—ABCC3—Methotrexate—systemic scleroderma	0.0594	0.102	CbGbCtD
Nifedipine—CYP1A2—Pentoxifylline—systemic scleroderma	0.0426	0.0729	CbGbCtD
Nifedipine—CYP1A2—Leflunomide—systemic scleroderma	0.0406	0.0695	CbGbCtD
Nifedipine—ABCB1—Lisinopril—systemic scleroderma	0.0373	0.0637	CbGbCtD
Nifedipine—CYP2C9—Leflunomide—systemic scleroderma	0.0366	0.0626	CbGbCtD
Nifedipine—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0337	0.0577	CbGbCtD
Nifedipine—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0324	0.0555	CbGbCtD
Nifedipine—ABCB1—Captopril—systemic scleroderma	0.0279	0.0477	CbGbCtD
Nifedipine—ABCC2—Methotrexate—systemic scleroderma	0.027	0.0462	CbGbCtD
Nifedipine—CYP2D6—Captopril—systemic scleroderma	0.0263	0.0449	CbGbCtD
Nifedipine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.022	0.0375	CbGbCtD
Nifedipine—ABCB1—Prednisone—systemic scleroderma	0.0176	0.03	CbGbCtD
Nifedipine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0132	0.0225	CbGbCtD
Nifedipine—CYP2C9—cardial valve—systemic scleroderma	0.0113	0.177	CbGeAlD
Nifedipine—CYP3A4—Prednisone—systemic scleroderma	0.0105	0.018	CbGbCtD
Nifedipine—ABCB1—Methotrexate—systemic scleroderma	0.00881	0.0151	CbGbCtD
Nifedipine—CALM2—artery—systemic scleroderma	0.00231	0.0362	CbGeAlD
Nifedipine—CALM1—artery—systemic scleroderma	0.0023	0.036	CbGeAlD
Nifedipine—CACNA1S—tendon—systemic scleroderma	0.00199	0.0311	CbGeAlD
Nifedipine—CALM2—endothelium—systemic scleroderma	0.00195	0.0306	CbGeAlD
Nifedipine—CALM1—endothelium—systemic scleroderma	0.00194	0.0304	CbGeAlD
Nifedipine—CALM2—blood vessel—systemic scleroderma	0.0018	0.0282	CbGeAlD
Nifedipine—CALM1—blood vessel—systemic scleroderma	0.00179	0.028	CbGeAlD
Nifedipine—CACNA1H—smooth muscle tissue—systemic scleroderma	0.00169	0.0264	CbGeAlD
Nifedipine—KCNA1—tendon—systemic scleroderma	0.00157	0.0245	CbGeAlD
Nifedipine—CACNA1C—connective tissue—systemic scleroderma	0.0014	0.022	CbGeAlD
Nifedipine—CACNA1C—smooth muscle tissue—systemic scleroderma	0.00128	0.0201	CbGeAlD
Nifedipine—CACNB2—digestive system—systemic scleroderma	0.00126	0.0197	CbGeAlD
Nifedipine—CACNB2—tendon—systemic scleroderma	0.0012	0.0187	CbGeAlD
Nifedipine—CACNA2D1—tendon—systemic scleroderma	0.00112	0.0176	CbGeAlD
Nifedipine—CALM3—smooth muscle tissue—systemic scleroderma	0.00108	0.0168	CbGeAlD
Nifedipine—CACNB2—lung—systemic scleroderma	0.00105	0.0164	CbGeAlD
Nifedipine—CACNA1C—digestive system—systemic scleroderma	0.00101	0.0159	CbGeAlD
Nifedipine—CACNA2D1—lung—systemic scleroderma	0.000986	0.0154	CbGeAlD
Nifedipine—CALM2—connective tissue—systemic scleroderma	0.000924	0.0144	CbGeAlD
Nifedipine—ABCC3—digestive system—systemic scleroderma	0.000923	0.0144	CbGeAlD
Nifedipine—CALM1—connective tissue—systemic scleroderma	0.000919	0.0144	CbGeAlD
Nifedipine—CACNA1D—lung—systemic scleroderma	0.000918	0.0144	CbGeAlD
Nifedipine—CACNA1C—lung—systemic scleroderma	0.000847	0.0132	CbGeAlD
Nifedipine—CALM2—smooth muscle tissue—systemic scleroderma	0.000845	0.0132	CbGeAlD
Nifedipine—CALM1—smooth muscle tissue—systemic scleroderma	0.000841	0.0132	CbGeAlD
Nifedipine—CALM2—skin of body—systemic scleroderma	0.000834	0.013	CbGeAlD
Nifedipine—CALM1—skin of body—systemic scleroderma	0.00083	0.013	CbGeAlD
Nifedipine—CYP2A6—lung—systemic scleroderma	0.000823	0.0129	CbGeAlD
Nifedipine—CALM3—tendon—systemic scleroderma	0.000809	0.0126	CbGeAlD
Nifedipine—ABCC3—lung—systemic scleroderma	0.000771	0.0121	CbGeAlD
Nifedipine—ABCC2—digestive system—systemic scleroderma	0.000737	0.0115	CbGeAlD
Nifedipine—ABCB1—blood vessel—systemic scleroderma	0.000716	0.0112	CbGeAlD
Nifedipine—CALM3—lung—systemic scleroderma	0.00071	0.0111	CbGeAlD
Nifedipine—ABCC2—tendon—systemic scleroderma	0.000702	0.011	CbGeAlD
Nifedipine—CALM2—digestive system—systemic scleroderma	0.000667	0.0104	CbGeAlD
Nifedipine—CALM1—digestive system—systemic scleroderma	0.000664	0.0104	CbGeAlD
Nifedipine—CYP1A1—skin of body—systemic scleroderma	0.000638	0.00998	CbGeAlD
Nifedipine—CALM2—tendon—systemic scleroderma	0.000635	0.00993	CbGeAlD
Nifedipine—CALM1—tendon—systemic scleroderma	0.000632	0.00988	CbGeAlD
Nifedipine—CYP2B6—skin of body—systemic scleroderma	0.00062	0.0097	CbGeAlD
Nifedipine—CALM2—lung—systemic scleroderma	0.000557	0.00871	CbGeAlD
Nifedipine—CALM1—lung—systemic scleroderma	0.000555	0.00867	CbGeAlD
Nifedipine—CYP1A2—digestive system—systemic scleroderma	0.000517	0.00809	CbGeAlD
Nifedipine—CYP1A1—digestive system—systemic scleroderma	0.00051	0.00798	CbGeAlD
Nifedipine—CYP3A5—digestive system—systemic scleroderma	0.000499	0.0078	CbGeAlD
Nifedipine—CYP2B6—digestive system—systemic scleroderma	0.000496	0.00776	CbGeAlD
Nifedipine—CYP2C9—digestive system—systemic scleroderma	0.000491	0.00768	CbGeAlD
Nifedipine—CYP2E1—digestive system—systemic scleroderma	0.000465	0.00728	CbGeAlD
Nifedipine—CYP2E1—tendon—systemic scleroderma	0.000443	0.00693	CbGeAlD
Nifedipine—CYP1A2—lung—systemic scleroderma	0.000432	0.00676	CbGeAlD
Nifedipine—CYP1A1—lung—systemic scleroderma	0.000426	0.00667	CbGeAlD
Nifedipine—CYP3A5—lung—systemic scleroderma	0.000417	0.00652	CbGeAlD
Nifedipine—CYP2B6—lung—systemic scleroderma	0.000414	0.00648	CbGeAlD
Nifedipine—CYP2E1—lung—systemic scleroderma	0.000389	0.00608	CbGeAlD
Nifedipine—CYP3A4—digestive system—systemic scleroderma	0.000375	0.00586	CbGeAlD
Nifedipine—CYP2D6—digestive system—systemic scleroderma	0.000369	0.00576	CbGeAlD
Nifedipine—ABCB1—digestive system—systemic scleroderma	0.000265	0.00415	CbGeAlD
Nifedipine—ABCB1—lung—systemic scleroderma	0.000221	0.00346	CbGeAlD
Nifedipine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000492	CcSEcCtD
Nifedipine—Hypotension—Lisinopril—systemic scleroderma	0.000167	0.000491	CcSEcCtD
Nifedipine—Dizziness—Captopril—systemic scleroderma	0.000167	0.000491	CcSEcCtD
Nifedipine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000166	0.00049	CcSEcCtD
Nifedipine—Urticaria—Leflunomide—systemic scleroderma	0.000165	0.000486	CcSEcCtD
Nifedipine—Body temperature increased—Leflunomide—systemic scleroderma	0.000164	0.000483	CcSEcCtD
Nifedipine—Abdominal pain—Leflunomide—systemic scleroderma	0.000164	0.000483	CcSEcCtD
Nifedipine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000163	0.000481	CcSEcCtD
Nifedipine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000163	0.00048	CcSEcCtD
Nifedipine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000163	0.00048	CcSEcCtD
Nifedipine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000163	0.00048	CcSEcCtD
Nifedipine—Breast disorder—Methotrexate—systemic scleroderma	0.000163	0.000479	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000162	0.000479	CcSEcCtD
Nifedipine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000479	CcSEcCtD
Nifedipine—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000162	0.000478	CcSEcCtD
Nifedipine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000162	0.000477	CcSEcCtD
Nifedipine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000162	0.000477	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000477	CcSEcCtD
Nifedipine—Insomnia—Lisinopril—systemic scleroderma	0.000161	0.000475	CcSEcCtD
Nifedipine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000474	CcSEcCtD
Nifedipine—Paraesthesia—Lisinopril—systemic scleroderma	0.00016	0.000472	CcSEcCtD
Nifedipine—Vomiting—Captopril—systemic scleroderma	0.00016	0.000472	CcSEcCtD
Nifedipine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000159	0.00047	CcSEcCtD
Nifedipine—Dyspnoea—Lisinopril—systemic scleroderma	0.000159	0.000468	CcSEcCtD
Nifedipine—Rash—Captopril—systemic scleroderma	0.000159	0.000468	CcSEcCtD
Nifedipine—Dermatitis—Captopril—systemic scleroderma	0.000159	0.000467	CcSEcCtD
Nifedipine—Somnolence—Lisinopril—systemic scleroderma	0.000159	0.000467	CcSEcCtD
Nifedipine—Headache—Captopril—systemic scleroderma	0.000158	0.000465	CcSEcCtD
Nifedipine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000464	CcSEcCtD
Nifedipine—Dyspepsia—Lisinopril—systemic scleroderma	0.000157	0.000463	CcSEcCtD
Nifedipine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000156	0.000461	CcSEcCtD
Nifedipine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000156	0.000461	CcSEcCtD
Nifedipine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000156	0.00046	CcSEcCtD
Nifedipine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000156	0.00046	CcSEcCtD
Nifedipine—Decreased appetite—Lisinopril—systemic scleroderma	0.000155	0.000457	CcSEcCtD
Nifedipine—Eosinophilia—Methotrexate—systemic scleroderma	0.000154	0.000454	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000154	0.000454	CcSEcCtD
Nifedipine—Fatigue—Lisinopril—systemic scleroderma	0.000154	0.000453	CcSEcCtD
Nifedipine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000453	CcSEcCtD
Nifedipine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000451	CcSEcCtD
Nifedipine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000451	CcSEcCtD
Nifedipine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000153	0.000451	CcSEcCtD
Nifedipine—Constipation—Lisinopril—systemic scleroderma	0.000152	0.000449	CcSEcCtD
Nifedipine—Pain—Lisinopril—systemic scleroderma	0.000152	0.000449	CcSEcCtD
Nifedipine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000449	CcSEcCtD
Nifedipine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000447	CcSEcCtD
Nifedipine—Bradycardia—Prednisone—systemic scleroderma	0.000152	0.000447	CcSEcCtD
Nifedipine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000445	CcSEcCtD
Nifedipine—Diarrhoea—Azathioprine—systemic scleroderma	0.00015	0.000443	CcSEcCtD
Nifedipine—Haemoglobin—Prednisone—systemic scleroderma	0.00015	0.000441	CcSEcCtD
Nifedipine—Nausea—Captopril—systemic scleroderma	0.00015	0.000441	CcSEcCtD
Nifedipine—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000149	0.00044	CcSEcCtD
Nifedipine—Haemorrhage—Prednisone—systemic scleroderma	0.000149	0.000439	CcSEcCtD
Nifedipine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000439	CcSEcCtD
Nifedipine—Asthenia—Leflunomide—systemic scleroderma	0.000149	0.000439	CcSEcCtD
Nifedipine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000147	0.000433	CcSEcCtD
Nifedipine—Pruritus—Leflunomide—systemic scleroderma	0.000147	0.000433	CcSEcCtD
Nifedipine—Connective tissue disorder—Prednisone—systemic scleroderma	0.000146	0.000432	CcSEcCtD
Nifedipine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000146	0.00043	CcSEcCtD
Nifedipine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000146	0.00043	CcSEcCtD
Nifedipine—Dysuria—Methotrexate—systemic scleroderma	0.000146	0.000429	CcSEcCtD
Nifedipine—Dizziness—Azathioprine—systemic scleroderma	0.000145	0.000428	CcSEcCtD
Nifedipine—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000145	0.000426	CcSEcCtD
Nifedipine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000143	0.000422	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000419	CcSEcCtD
Nifedipine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000142	0.000419	CcSEcCtD
Nifedipine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000142	0.000419	CcSEcCtD
Nifedipine—Diarrhoea—Leflunomide—systemic scleroderma	0.000142	0.000418	CcSEcCtD
Nifedipine—Urticaria—Lisinopril—systemic scleroderma	0.000142	0.000417	CcSEcCtD
Nifedipine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000416	CcSEcCtD
Nifedipine—Body temperature increased—Lisinopril—systemic scleroderma	0.000141	0.000415	CcSEcCtD
Nifedipine—Abdominal pain—Lisinopril—systemic scleroderma	0.000141	0.000415	CcSEcCtD
Nifedipine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00014	0.000413	CcSEcCtD
Nifedipine—Pruritus—Mycophenolic acid—systemic scleroderma	0.00014	0.000413	CcSEcCtD
Nifedipine—Vomiting—Azathioprine—systemic scleroderma	0.00014	0.000412	CcSEcCtD
Nifedipine—Eye disorder—Prednisone—systemic scleroderma	0.000139	0.00041	CcSEcCtD
Nifedipine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000139	0.00041	CcSEcCtD
Nifedipine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000409	CcSEcCtD
Nifedipine—Rash—Azathioprine—systemic scleroderma	0.000139	0.000408	CcSEcCtD
Nifedipine—Dermatitis—Azathioprine—systemic scleroderma	0.000138	0.000408	CcSEcCtD
Nifedipine—Flushing—Prednisone—systemic scleroderma	0.000138	0.000408	CcSEcCtD
Nifedipine—Headache—Azathioprine—systemic scleroderma	0.000138	0.000406	CcSEcCtD
Nifedipine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000138	0.000405	CcSEcCtD
Nifedipine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000138	0.000405	CcSEcCtD
Nifedipine—Dizziness—Leflunomide—systemic scleroderma	0.000137	0.000404	CcSEcCtD
Nifedipine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000136	0.0004	CcSEcCtD
Nifedipine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000135	0.000399	CcSEcCtD
Nifedipine—Angiopathy—Prednisone—systemic scleroderma	0.000135	0.000399	CcSEcCtD
Nifedipine—Conjunctivitis—Methotrexate—systemic scleroderma	0.000135	0.000397	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000135	0.000397	CcSEcCtD
Nifedipine—Immune system disorder—Prednisone—systemic scleroderma	0.000135	0.000397	CcSEcCtD
Nifedipine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000394	CcSEcCtD
Nifedipine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000394	CcSEcCtD
Nifedipine—Arrhythmia—Prednisone—systemic scleroderma	0.000133	0.000392	CcSEcCtD
Nifedipine—Sweating—Methotrexate—systemic scleroderma	0.000133	0.000392	CcSEcCtD
Nifedipine—Haematuria—Methotrexate—systemic scleroderma	0.000132	0.00039	CcSEcCtD
Nifedipine—Vomiting—Leflunomide—systemic scleroderma	0.000132	0.000389	CcSEcCtD
Nifedipine—Alopecia—Prednisone—systemic scleroderma	0.000132	0.000388	CcSEcCtD
Nifedipine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000131	0.000387	CcSEcCtD
Nifedipine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000131	0.000387	CcSEcCtD
Nifedipine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000131	0.000386	CcSEcCtD
Nifedipine—Epistaxis—Methotrexate—systemic scleroderma	0.000131	0.000386	CcSEcCtD
Nifedipine—Rash—Leflunomide—systemic scleroderma	0.000131	0.000386	CcSEcCtD
Nifedipine—Dermatitis—Leflunomide—systemic scleroderma	0.000131	0.000385	CcSEcCtD
Nifedipine—Mental disorder—Prednisone—systemic scleroderma	0.000131	0.000385	CcSEcCtD
Nifedipine—Nausea—Azathioprine—systemic scleroderma	0.000131	0.000385	CcSEcCtD
Nifedipine—Headache—Leflunomide—systemic scleroderma	0.00013	0.000383	CcSEcCtD
Nifedipine—Malnutrition—Prednisone—systemic scleroderma	0.00013	0.000382	CcSEcCtD
Nifedipine—Erythema—Prednisone—systemic scleroderma	0.00013	0.000382	CcSEcCtD
Nifedipine—Agranulocytosis—Methotrexate—systemic scleroderma	0.00013	0.000382	CcSEcCtD
Nifedipine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000129	0.000379	CcSEcCtD
Nifedipine—Asthenia—Lisinopril—systemic scleroderma	0.000128	0.000377	CcSEcCtD
Nifedipine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000128	0.000376	CcSEcCtD
Nifedipine—Pruritus—Lisinopril—systemic scleroderma	0.000126	0.000372	CcSEcCtD
Nifedipine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000126	0.000371	CcSEcCtD
Nifedipine—Haemoglobin—Methotrexate—systemic scleroderma	0.000125	0.000369	CcSEcCtD
Nifedipine—Rash—Mycophenolic acid—systemic scleroderma	0.000125	0.000368	CcSEcCtD
Nifedipine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000125	0.000367	CcSEcCtD
Nifedipine—Haemorrhage—Methotrexate—systemic scleroderma	0.000125	0.000367	CcSEcCtD
Nifedipine—Hepatitis—Methotrexate—systemic scleroderma	0.000125	0.000367	CcSEcCtD
Nifedipine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000124	0.000366	CcSEcCtD
Nifedipine—Headache—Mycophenolic acid—systemic scleroderma	0.000124	0.000365	CcSEcCtD
Nifedipine—Pharyngitis—Methotrexate—systemic scleroderma	0.000124	0.000364	CcSEcCtD
Nifedipine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000124	0.000364	CcSEcCtD
Nifedipine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000124	0.000364	CcSEcCtD
Nifedipine—Nausea—Leflunomide—systemic scleroderma	0.000123	0.000363	CcSEcCtD
Nifedipine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000123	0.000363	CcSEcCtD
Nifedipine—Vision blurred—Prednisone—systemic scleroderma	0.000122	0.00036	CcSEcCtD
Nifedipine—Urethral disorder—Methotrexate—systemic scleroderma	0.000122	0.00036	CcSEcCtD
Nifedipine—Diarrhoea—Lisinopril—systemic scleroderma	0.000122	0.000359	CcSEcCtD
Nifedipine—Ill-defined disorder—Prednisone—systemic scleroderma	0.00012	0.000355	CcSEcCtD
Nifedipine—Visual impairment—Methotrexate—systemic scleroderma	0.00012	0.000354	CcSEcCtD
Nifedipine—Anaemia—Prednisone—systemic scleroderma	0.00012	0.000353	CcSEcCtD
Nifedipine—Agitation—Prednisone—systemic scleroderma	0.000119	0.000351	CcSEcCtD
Nifedipine—Angioedema—Prednisone—systemic scleroderma	0.000119	0.000349	CcSEcCtD
Nifedipine—Dizziness—Lisinopril—systemic scleroderma	0.000118	0.000347	CcSEcCtD
Nifedipine—Erythema multiforme—Methotrexate—systemic scleroderma	0.000118	0.000347	CcSEcCtD
Nifedipine—Nausea—Mycophenolic acid—systemic scleroderma	0.000118	0.000346	CcSEcCtD
Nifedipine—Malaise—Prednisone—systemic scleroderma	0.000117	0.000345	CcSEcCtD
Nifedipine—Vertigo—Prednisone—systemic scleroderma	0.000117	0.000344	CcSEcCtD
Nifedipine—Eye disorder—Methotrexate—systemic scleroderma	0.000116	0.000343	CcSEcCtD
Nifedipine—Syncope—Prednisone—systemic scleroderma	0.000116	0.000343	CcSEcCtD
Nifedipine—Tinnitus—Methotrexate—systemic scleroderma	0.000116	0.000342	CcSEcCtD
Nifedipine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000116	0.000341	CcSEcCtD
Nifedipine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000115	0.000339	CcSEcCtD
Nifedipine—Loss of consciousness—Prednisone—systemic scleroderma	0.000114	0.000336	CcSEcCtD
Nifedipine—Vomiting—Lisinopril—systemic scleroderma	0.000113	0.000334	CcSEcCtD
Nifedipine—Angiopathy—Methotrexate—systemic scleroderma	0.000113	0.000333	CcSEcCtD
Nifedipine—Immune system disorder—Methotrexate—systemic scleroderma	0.000113	0.000332	CcSEcCtD
Nifedipine—Rash—Lisinopril—systemic scleroderma	0.000112	0.000331	CcSEcCtD
Nifedipine—Dermatitis—Lisinopril—systemic scleroderma	0.000112	0.000331	CcSEcCtD
Nifedipine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000112	0.000331	CcSEcCtD
Nifedipine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000112	0.00033	CcSEcCtD
Nifedipine—Chills—Methotrexate—systemic scleroderma	0.000112	0.000329	CcSEcCtD
Nifedipine—Headache—Lisinopril—systemic scleroderma	0.000112	0.000329	CcSEcCtD
Nifedipine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000111	0.000326	CcSEcCtD
Nifedipine—Myalgia—Prednisone—systemic scleroderma	0.00011	0.000326	CcSEcCtD
Nifedipine—Arthralgia—Prednisone—systemic scleroderma	0.00011	0.000326	CcSEcCtD
Nifedipine—Anxiety—Prednisone—systemic scleroderma	0.00011	0.000324	CcSEcCtD
Nifedipine—Alopecia—Methotrexate—systemic scleroderma	0.00011	0.000324	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00011	0.000323	CcSEcCtD
Nifedipine—Discomfort—Prednisone—systemic scleroderma	0.000109	0.000322	CcSEcCtD
Nifedipine—Mental disorder—Methotrexate—systemic scleroderma	0.000109	0.000322	CcSEcCtD
Nifedipine—Malnutrition—Methotrexate—systemic scleroderma	0.000108	0.00032	CcSEcCtD
Nifedipine—Erythema—Methotrexate—systemic scleroderma	0.000108	0.00032	CcSEcCtD
Nifedipine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000107	0.000315	CcSEcCtD
Nifedipine—Dysgeusia—Methotrexate—systemic scleroderma	0.000106	0.000313	CcSEcCtD
Nifedipine—Nausea—Lisinopril—systemic scleroderma	0.000106	0.000312	CcSEcCtD
Nifedipine—Oedema—Prednisone—systemic scleroderma	0.000106	0.000312	CcSEcCtD
Nifedipine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000106	0.000312	CcSEcCtD
Nifedipine—Back pain—Methotrexate—systemic scleroderma	0.000105	0.000309	CcSEcCtD
Nifedipine—Shock—Prednisone—systemic scleroderma	0.000104	0.000307	CcSEcCtD
Nifedipine—Nervous system disorder—Prednisone—systemic scleroderma	0.000104	0.000306	CcSEcCtD
Nifedipine—Tachycardia—Prednisone—systemic scleroderma	0.000103	0.000305	CcSEcCtD
Nifedipine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000304	CcSEcCtD
Nifedipine—Skin disorder—Prednisone—systemic scleroderma	0.000103	0.000303	CcSEcCtD
Nifedipine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000102	0.000302	CcSEcCtD
Nifedipine—Vision blurred—Methotrexate—systemic scleroderma	0.000102	0.000301	CcSEcCtD
Nifedipine—Anorexia—Prednisone—systemic scleroderma	0.000101	0.000297	CcSEcCtD
Nifedipine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000101	0.000296	CcSEcCtD
Nifedipine—Anaemia—Methotrexate—systemic scleroderma	0.0001	0.000295	CcSEcCtD
Nifedipine—Vomiting—Mycophenolate mofetil—systemic scleroderma	9.93e-05	0.000293	CcSEcCtD
Nifedipine—Rash—Mycophenolate mofetil—systemic scleroderma	9.85e-05	0.00029	CcSEcCtD
Nifedipine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	9.84e-05	0.00029	CcSEcCtD
Nifedipine—Headache—Mycophenolate mofetil—systemic scleroderma	9.79e-05	0.000288	CcSEcCtD
Nifedipine—Malaise—Methotrexate—systemic scleroderma	9.78e-05	0.000288	CcSEcCtD
Nifedipine—Vertigo—Methotrexate—systemic scleroderma	9.74e-05	0.000287	CcSEcCtD
Nifedipine—Leukopenia—Methotrexate—systemic scleroderma	9.71e-05	0.000286	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	9.65e-05	0.000284	CcSEcCtD
Nifedipine—Insomnia—Prednisone—systemic scleroderma	9.58e-05	0.000282	CcSEcCtD
Nifedipine—Paraesthesia—Prednisone—systemic scleroderma	9.51e-05	0.00028	CcSEcCtD
Nifedipine—Cough—Methotrexate—systemic scleroderma	9.46e-05	0.000279	CcSEcCtD
Nifedipine—Dyspepsia—Prednisone—systemic scleroderma	9.32e-05	0.000275	CcSEcCtD
Nifedipine—Nausea—Mycophenolate mofetil—systemic scleroderma	9.28e-05	0.000273	CcSEcCtD
Nifedipine—Chest pain—Methotrexate—systemic scleroderma	9.23e-05	0.000272	CcSEcCtD
Nifedipine—Arthralgia—Methotrexate—systemic scleroderma	9.23e-05	0.000272	CcSEcCtD
Nifedipine—Myalgia—Methotrexate—systemic scleroderma	9.23e-05	0.000272	CcSEcCtD
Nifedipine—Decreased appetite—Prednisone—systemic scleroderma	9.21e-05	0.000271	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	9.17e-05	0.00027	CcSEcCtD
Nifedipine—Fatigue—Prednisone—systemic scleroderma	9.13e-05	0.000269	CcSEcCtD
Nifedipine—Discomfort—Methotrexate—systemic scleroderma	9.12e-05	0.000269	CcSEcCtD
Nifedipine—Constipation—Prednisone—systemic scleroderma	9.06e-05	0.000267	CcSEcCtD
Nifedipine—Confusional state—Methotrexate—systemic scleroderma	8.92e-05	0.000263	CcSEcCtD
Nifedipine—Anaphylactic shock—Methotrexate—systemic scleroderma	8.85e-05	0.000261	CcSEcCtD
Nifedipine—Feeling abnormal—Prednisone—systemic scleroderma	8.73e-05	0.000257	CcSEcCtD
Nifedipine—Nervous system disorder—Methotrexate—systemic scleroderma	8.68e-05	0.000256	CcSEcCtD
Nifedipine—Thrombocytopenia—Methotrexate—systemic scleroderma	8.67e-05	0.000255	CcSEcCtD
Nifedipine—Gastrointestinal pain—Prednisone—systemic scleroderma	8.66e-05	0.000255	CcSEcCtD
Nifedipine—Skin disorder—Methotrexate—systemic scleroderma	8.6e-05	0.000253	CcSEcCtD
Nifedipine—Hyperhidrosis—Methotrexate—systemic scleroderma	8.56e-05	0.000252	CcSEcCtD
Nifedipine—Anorexia—Methotrexate—systemic scleroderma	8.44e-05	0.000249	CcSEcCtD
Nifedipine—Urticaria—Prednisone—systemic scleroderma	8.41e-05	0.000248	CcSEcCtD
Nifedipine—Body temperature increased—Prednisone—systemic scleroderma	8.37e-05	0.000247	CcSEcCtD
Nifedipine—Abdominal pain—Prednisone—systemic scleroderma	8.37e-05	0.000247	CcSEcCtD
Nifedipine—Hypotension—Methotrexate—systemic scleroderma	8.27e-05	0.000244	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	8.06e-05	0.000238	CcSEcCtD
Nifedipine—Insomnia—Methotrexate—systemic scleroderma	8e-05	0.000236	CcSEcCtD
Nifedipine—Paraesthesia—Methotrexate—systemic scleroderma	7.95e-05	0.000234	CcSEcCtD
Nifedipine—Dyspnoea—Methotrexate—systemic scleroderma	7.89e-05	0.000233	CcSEcCtD
Nifedipine—Somnolence—Methotrexate—systemic scleroderma	7.87e-05	0.000232	CcSEcCtD
Nifedipine—Hypersensitivity—Prednisone—systemic scleroderma	7.8e-05	0.00023	CcSEcCtD
Nifedipine—Dyspepsia—Methotrexate—systemic scleroderma	7.79e-05	0.00023	CcSEcCtD
Nifedipine—Decreased appetite—Methotrexate—systemic scleroderma	7.69e-05	0.000227	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	7.64e-05	0.000225	CcSEcCtD
Nifedipine—Fatigue—Methotrexate—systemic scleroderma	7.63e-05	0.000225	CcSEcCtD
Nifedipine—Asthenia—Prednisone—systemic scleroderma	7.6e-05	0.000224	CcSEcCtD
Nifedipine—Pain—Methotrexate—systemic scleroderma	7.57e-05	0.000223	CcSEcCtD
Nifedipine—Pruritus—Prednisone—systemic scleroderma	7.49e-05	0.000221	CcSEcCtD
Nifedipine—Feeling abnormal—Methotrexate—systemic scleroderma	7.29e-05	0.000215	CcSEcCtD
Nifedipine—Diarrhoea—Prednisone—systemic scleroderma	7.25e-05	0.000214	CcSEcCtD
Nifedipine—Gastrointestinal pain—Methotrexate—systemic scleroderma	7.24e-05	0.000213	CcSEcCtD
Nifedipine—Urticaria—Methotrexate—systemic scleroderma	7.03e-05	0.000207	CcSEcCtD
Nifedipine—Dizziness—Prednisone—systemic scleroderma	7e-05	0.000206	CcSEcCtD
Nifedipine—Abdominal pain—Methotrexate—systemic scleroderma	7e-05	0.000206	CcSEcCtD
Nifedipine—Body temperature increased—Methotrexate—systemic scleroderma	7e-05	0.000206	CcSEcCtD
Nifedipine—Vomiting—Prednisone—systemic scleroderma	6.73e-05	0.000198	CcSEcCtD
Nifedipine—Rash—Prednisone—systemic scleroderma	6.68e-05	0.000197	CcSEcCtD
Nifedipine—Dermatitis—Prednisone—systemic scleroderma	6.67e-05	0.000197	CcSEcCtD
Nifedipine—Headache—Prednisone—systemic scleroderma	6.63e-05	0.000195	CcSEcCtD
Nifedipine—Hypersensitivity—Methotrexate—systemic scleroderma	6.52e-05	0.000192	CcSEcCtD
Nifedipine—Asthenia—Methotrexate—systemic scleroderma	6.35e-05	0.000187	CcSEcCtD
Nifedipine—Nausea—Prednisone—systemic scleroderma	6.29e-05	0.000185	CcSEcCtD
Nifedipine—Pruritus—Methotrexate—systemic scleroderma	6.26e-05	0.000185	CcSEcCtD
Nifedipine—Diarrhoea—Methotrexate—systemic scleroderma	6.06e-05	0.000178	CcSEcCtD
Nifedipine—Dizziness—Methotrexate—systemic scleroderma	5.85e-05	0.000172	CcSEcCtD
Nifedipine—Vomiting—Methotrexate—systemic scleroderma	5.63e-05	0.000166	CcSEcCtD
Nifedipine—Rash—Methotrexate—systemic scleroderma	5.58e-05	0.000164	CcSEcCtD
Nifedipine—Dermatitis—Methotrexate—systemic scleroderma	5.58e-05	0.000164	CcSEcCtD
Nifedipine—Headache—Methotrexate—systemic scleroderma	5.54e-05	0.000163	CcSEcCtD
Nifedipine—Nausea—Methotrexate—systemic scleroderma	5.26e-05	0.000155	CcSEcCtD
Nifedipine—CALM1—VEGFA-VEGFR2 Pathway—NOS3—systemic scleroderma	2.12e-05	0.00179	CbGpPWpGaD
Nifedipine—CACNB2—Metabolism—HSPG2—systemic scleroderma	2.12e-05	0.00179	CbGpPWpGaD
Nifedipine—CALM2—Endochondral Ossification—TGFB1—systemic scleroderma	2.11e-05	0.00178	CbGpPWpGaD
Nifedipine—CALM1—Endochondral Ossification—TGFB1—systemic scleroderma	2.11e-05	0.00178	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—SELP—systemic scleroderma	2.1e-05	0.00178	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—SELP—systemic scleroderma	2.1e-05	0.00178	CbGpPWpGaD
Nifedipine—CALM3—Signaling by VEGF—NOS3—systemic scleroderma	2.07e-05	0.00174	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—RHOB—systemic scleroderma	2.03e-05	0.00171	CbGpPWpGaD
Nifedipine—CACNA1D—Metabolism—HSPG2—systemic scleroderma	2e-05	0.00169	CbGpPWpGaD
Nifedipine—CALM2—Signaling by VEGF—NOS3—systemic scleroderma	2e-05	0.00169	CbGpPWpGaD
Nifedipine—CALM1—Signaling by VEGF—NOS3—systemic scleroderma	2e-05	0.00169	CbGpPWpGaD
Nifedipine—CACNB2—Axon guidance—MMP9—systemic scleroderma	1.97e-05	0.00167	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—RHOB—systemic scleroderma	1.96e-05	0.00166	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—RHOB—systemic scleroderma	1.96e-05	0.00166	CbGpPWpGaD
Nifedipine—CACNA1H—Developmental Biology—MMP9—systemic scleroderma	1.94e-05	0.00163	CbGpPWpGaD
Nifedipine—CACNB2—Developmental Biology—MMP2—systemic scleroderma	1.87e-05	0.00158	CbGpPWpGaD
Nifedipine—CACNA1D—Axon guidance—MMP9—systemic scleroderma	1.87e-05	0.00158	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—CSK—systemic scleroderma	1.85e-05	0.00156	CbGpPWpGaD
Nifedipine—CALM3—Platelet degranulation—TGFB1—systemic scleroderma	1.83e-05	0.00154	CbGpPWpGaD
Nifedipine—ABCC2—NRF2 pathway—TGFB1—systemic scleroderma	1.82e-05	0.00154	CbGpPWpGaD
Nifedipine—ABCB1—Allograft Rejection—IL1B—systemic scleroderma	1.8e-05	0.00152	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—CSK—systemic scleroderma	1.79e-05	0.00151	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—CSK—systemic scleroderma	1.79e-05	0.00151	CbGpPWpGaD
Nifedipine—CACNA1D—Developmental Biology—MMP2—systemic scleroderma	1.77e-05	0.0015	CbGpPWpGaD
Nifedipine—CALM1—Platelet degranulation—TGFB1—systemic scleroderma	1.77e-05	0.00149	CbGpPWpGaD
Nifedipine—CALM2—Platelet degranulation—TGFB1—systemic scleroderma	1.77e-05	0.00149	CbGpPWpGaD
Nifedipine—CACNA1C—Metabolism—HSPG2—systemic scleroderma	1.76e-05	0.00149	CbGpPWpGaD
Nifedipine—CALM3—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	1.74e-05	0.00147	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—ITGAM—systemic scleroderma	1.74e-05	0.00147	CbGpPWpGaD
Nifedipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	1.72e-05	0.00145	CbGpPWpGaD
Nifedipine—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	1.7e-05	0.00143	CbGpPWpGaD
Nifedipine—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	1.7e-05	0.00143	CbGpPWpGaD
Nifedipine—CALM2—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	1.68e-05	0.00142	CbGpPWpGaD
Nifedipine—CALM1—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	1.68e-05	0.00142	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—ITGAM—systemic scleroderma	1.68e-05	0.00142	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—ITGAM—systemic scleroderma	1.68e-05	0.00142	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	1.65e-05	0.0014	CbGpPWpGaD
Nifedipine—CACNA1S—Developmental Biology—MMP9—systemic scleroderma	1.64e-05	0.00139	CbGpPWpGaD
Nifedipine—CACNA1C—Axon guidance—MMP9—systemic scleroderma	1.64e-05	0.00139	CbGpPWpGaD
Nifedipine—CALM3—Myometrial Relaxation and Contraction Pathways—NOS3—systemic scleroderma	1.63e-05	0.00137	CbGpPWpGaD
Nifedipine—CACNB2—Metabolism—CTGF—systemic scleroderma	1.6e-05	0.00135	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—CSK—systemic scleroderma	1.6e-05	0.00135	CbGpPWpGaD
Nifedipine—CACNA1H—Developmental Biology—TGFB1—systemic scleroderma	1.6e-05	0.00135	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—HSPG2—systemic scleroderma	1.58e-05	0.00133	CbGpPWpGaD
Nifedipine—CALM2—Myometrial Relaxation and Contraction Pathways—NOS3—systemic scleroderma	1.57e-05	0.00133	CbGpPWpGaD
Nifedipine—CALM1—Myometrial Relaxation and Contraction Pathways—NOS3—systemic scleroderma	1.57e-05	0.00133	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—CD247—systemic scleroderma	1.57e-05	0.00132	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—ITGAM—systemic scleroderma	1.57e-05	0.00132	CbGpPWpGaD
Nifedipine—CACNA1C—Developmental Biology—MMP2—systemic scleroderma	1.56e-05	0.00132	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—CSK—systemic scleroderma	1.55e-05	0.00131	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—CSK—systemic scleroderma	1.55e-05	0.00131	CbGpPWpGaD
Nifedipine—CACNA1D—Metabolism—CTGF—systemic scleroderma	1.52e-05	0.00128	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	1.52e-05	0.00128	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—CD247—systemic scleroderma	1.51e-05	0.00128	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—ITGAM—systemic scleroderma	1.51e-05	0.00128	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—ITGAM—systemic scleroderma	1.51e-05	0.00128	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—CD247—systemic scleroderma	1.51e-05	0.00128	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—CD247—systemic scleroderma	1.5e-05	0.00127	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—TNFAIP3—systemic scleroderma	1.47e-05	0.00124	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—CD247—systemic scleroderma	1.45e-05	0.00123	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—CD247—systemic scleroderma	1.45e-05	0.00123	CbGpPWpGaD
Nifedipine—CYP2A6—NRF2 pathway—TGFB1—systemic scleroderma	1.44e-05	0.00121	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—TNFAIP3—systemic scleroderma	1.42e-05	0.0012	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—TNFAIP3—systemic scleroderma	1.42e-05	0.0012	CbGpPWpGaD
Nifedipine—CACNB2—Developmental Biology—MMP9—systemic scleroderma	1.41e-05	0.00119	CbGpPWpGaD
Nifedipine—ABCB1—Allograft Rejection—TGFB1—systemic scleroderma	1.4e-05	0.00118	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—BLK—systemic scleroderma	1.39e-05	0.00117	CbGpPWpGaD
Nifedipine—CALM3—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	1.38e-05	0.00117	CbGpPWpGaD
Nifedipine—CACNA1S—Developmental Biology—TGFB1—systemic scleroderma	1.35e-05	0.00114	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—BLK—systemic scleroderma	1.35e-05	0.00114	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—BLK—systemic scleroderma	1.35e-05	0.00114	CbGpPWpGaD
Nifedipine—CALM1—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	1.34e-05	0.00113	CbGpPWpGaD
Nifedipine—CALM2—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	1.34e-05	0.00113	CbGpPWpGaD
Nifedipine—CACNA1C—Metabolism—CTGF—systemic scleroderma	1.33e-05	0.00113	CbGpPWpGaD
Nifedipine—CACNA1D—Developmental Biology—MMP9—systemic scleroderma	1.33e-05	0.00113	CbGpPWpGaD
Nifedipine—CALM3—Disease—SMAD7—systemic scleroderma	1.27e-05	0.00107	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.25e-05	0.00106	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	1.23e-05	0.00104	CbGpPWpGaD
Nifedipine—CALM1—Disease—SMAD7—systemic scleroderma	1.23e-05	0.00104	CbGpPWpGaD
Nifedipine—CALM2—Disease—SMAD7—systemic scleroderma	1.23e-05	0.00104	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—CTGF—systemic scleroderma	1.2e-05	0.00101	CbGpPWpGaD
Nifedipine—CACNA1C—Developmental Biology—MMP9—systemic scleroderma	1.17e-05	0.000989	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—RHOB—systemic scleroderma	1.17e-05	0.000983	CbGpPWpGaD
Nifedipine—CALM3—Disease—TGFBI—systemic scleroderma	1.16e-05	0.000981	CbGpPWpGaD
Nifedipine—CACNB2—Developmental Biology—TGFB1—systemic scleroderma	1.16e-05	0.00098	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.15e-05	0.00097	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—CTLA4—systemic scleroderma	1.14e-05	0.000961	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—RHOB—systemic scleroderma	1.13e-05	0.000951	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—RHOB—systemic scleroderma	1.13e-05	0.000951	CbGpPWpGaD
Nifedipine—CALM2—Disease—TGFBI—systemic scleroderma	1.12e-05	0.000949	CbGpPWpGaD
Nifedipine—CALM1—Disease—TGFBI—systemic scleroderma	1.12e-05	0.000949	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—CTLA4—systemic scleroderma	1.1e-05	0.00093	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—CTLA4—systemic scleroderma	1.1e-05	0.00093	CbGpPWpGaD
Nifedipine—CACNA1D—Developmental Biology—TGFB1—systemic scleroderma	1.1e-05	0.000928	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—HSPG2—systemic scleroderma	1.08e-05	0.00091	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	1.05e-05	0.00089	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—HSPG2—systemic scleroderma	9.89e-06	0.000834	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CSK—systemic scleroderma	9.7e-06	0.000818	CbGpPWpGaD
Nifedipine—CACNA1C—Developmental Biology—TGFB1—systemic scleroderma	9.66e-06	0.000815	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IRF5—systemic scleroderma	9.54e-06	0.000805	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—HLA-DQB1—systemic scleroderma	9.38e-06	0.000792	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CSK—systemic scleroderma	9.38e-06	0.000792	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CSK—systemic scleroderma	9.38e-06	0.000792	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	9.35e-06	0.000789	CbGpPWpGaD
Nifedipine—CALM3—Disease—HSPG2—systemic scleroderma	9.27e-06	0.000782	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IRF5—systemic scleroderma	9.23e-06	0.000779	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IRF5—systemic scleroderma	9.23e-06	0.000779	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IRF8—systemic scleroderma	9.12e-06	0.000769	CbGpPWpGaD
Nifedipine—CALM3—Immune System—ITGAM—systemic scleroderma	9.12e-06	0.000769	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CD247—systemic scleroderma	9.12e-06	0.000769	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—HLA-DQB1—systemic scleroderma	9.07e-06	0.000766	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—HLA-DQB1—systemic scleroderma	9.07e-06	0.000766	CbGpPWpGaD
Nifedipine—CALM2—Disease—HSPG2—systemic scleroderma	8.97e-06	0.000757	CbGpPWpGaD
Nifedipine—CALM1—Disease—HSPG2—systemic scleroderma	8.97e-06	0.000757	CbGpPWpGaD
Nifedipine—CALM3—Disease—CSK—systemic scleroderma	8.95e-06	0.000755	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SMAD7—systemic scleroderma	8.9e-06	0.000751	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—CD40LG—systemic scleroderma	8.86e-06	0.000748	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IRF8—systemic scleroderma	8.82e-06	0.000744	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IRF8—systemic scleroderma	8.82e-06	0.000744	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CD247—systemic scleroderma	8.82e-06	0.000744	CbGpPWpGaD
Nifedipine—CALM2—Immune System—ITGAM—systemic scleroderma	8.82e-06	0.000744	CbGpPWpGaD
Nifedipine—CALM1—Immune System—ITGAM—systemic scleroderma	8.82e-06	0.000744	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CD247—systemic scleroderma	8.82e-06	0.000744	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—MMP1—systemic scleroderma	8.71e-06	0.000735	CbGpPWpGaD
Nifedipine—CALM1—Disease—CSK—systemic scleroderma	8.66e-06	0.000731	CbGpPWpGaD
Nifedipine—CALM2—Disease—CSK—systemic scleroderma	8.66e-06	0.000731	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SMAD7—systemic scleroderma	8.61e-06	0.000726	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SMAD7—systemic scleroderma	8.61e-06	0.000726	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—CD40LG—systemic scleroderma	8.57e-06	0.000723	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—CD40LG—systemic scleroderma	8.57e-06	0.000723	CbGpPWpGaD
Nifedipine—CALM3—Immune System—TNFAIP3—systemic scleroderma	8.54e-06	0.00072	CbGpPWpGaD
Nifedipine—CALM3—Immune System—BLK—systemic scleroderma	8.43e-06	0.000712	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—MMP1—systemic scleroderma	8.43e-06	0.000711	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—MMP1—systemic scleroderma	8.43e-06	0.000711	CbGpPWpGaD
Nifedipine—CALM3—Disease—CD247—systemic scleroderma	8.42e-06	0.00071	CbGpPWpGaD
Nifedipine—CALM2—Immune System—TNFAIP3—systemic scleroderma	8.26e-06	0.000697	CbGpPWpGaD
Nifedipine—CALM1—Immune System—TNFAIP3—systemic scleroderma	8.26e-06	0.000697	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—CTGF—systemic scleroderma	8.17e-06	0.00069	CbGpPWpGaD
Nifedipine—CALM2—Immune System—BLK—systemic scleroderma	8.16e-06	0.000689	CbGpPWpGaD
Nifedipine—CALM1—Immune System—BLK—systemic scleroderma	8.16e-06	0.000689	CbGpPWpGaD
Nifedipine—CALM1—Disease—CD247—systemic scleroderma	8.14e-06	0.000687	CbGpPWpGaD
Nifedipine—CALM2—Disease—CD247—systemic scleroderma	8.14e-06	0.000687	CbGpPWpGaD
Nifedipine—CALM3—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	8.1e-06	0.000684	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	7.99e-06	0.000674	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—HSPG2—systemic scleroderma	7.98e-06	0.000673	CbGpPWpGaD
Nifedipine—CALM1—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	7.84e-06	0.000661	CbGpPWpGaD
Nifedipine—CALM2—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	7.84e-06	0.000661	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—HSPG2—systemic scleroderma	7.81e-06	0.000659	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—HSPG2—systemic scleroderma	7.8e-06	0.000658	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—HSPG2—systemic scleroderma	7.76e-06	0.000655	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—HSPG2—systemic scleroderma	7.51e-06	0.000634	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—HSPG2—systemic scleroderma	7.51e-06	0.000634	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—CTGF—systemic scleroderma	7.49e-06	0.000632	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—HSPG2—systemic scleroderma	7.37e-06	0.000622	CbGpPWpGaD
Nifedipine—CACNB2—Metabolism—NOS3—systemic scleroderma	6.98e-06	0.000589	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CTLA4—systemic scleroderma	6.91e-06	0.000583	CbGpPWpGaD
Nifedipine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	6.9e-06	0.000582	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—RHOB—systemic scleroderma	6.88e-06	0.000581	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—HSPG2—systemic scleroderma	6.75e-06	0.00057	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CTLA4—systemic scleroderma	6.68e-06	0.000564	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CTLA4—systemic scleroderma	6.68e-06	0.000564	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—RHOB—systemic scleroderma	6.66e-06	0.000562	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—RHOB—systemic scleroderma	6.66e-06	0.000562	CbGpPWpGaD
Nifedipine—CACNA1D—Metabolism—NOS3—systemic scleroderma	6.61e-06	0.000558	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—HSPG2—systemic scleroderma	6.49e-06	0.000548	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—NOS3—systemic scleroderma	6.32e-06	0.000533	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—HSPG2—systemic scleroderma	6.28e-06	0.00053	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—HSPG2—systemic scleroderma	6.28e-06	0.00053	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CSK—systemic scleroderma	6.27e-06	0.000529	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—NOS3—systemic scleroderma	6.11e-06	0.000516	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—NOS3—systemic scleroderma	6.11e-06	0.000516	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CSK—systemic scleroderma	6.06e-06	0.000512	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CSK—systemic scleroderma	6.06e-06	0.000512	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—CTGF—systemic scleroderma	6.04e-06	0.00051	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—EDN1—systemic scleroderma	5.95e-06	0.000502	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—CTGF—systemic scleroderma	5.92e-06	0.0005	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—CTGF—systemic scleroderma	5.91e-06	0.000499	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—HSPG2—systemic scleroderma	5.88e-06	0.000496	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—CTGF—systemic scleroderma	5.88e-06	0.000496	CbGpPWpGaD
Nifedipine—CACNA1C—Metabolism—NOS3—systemic scleroderma	5.81e-06	0.00049	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—EDN1—systemic scleroderma	5.75e-06	0.000486	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—EDN1—systemic scleroderma	5.75e-06	0.000486	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—CTGF—systemic scleroderma	5.69e-06	0.00048	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—CTGF—systemic scleroderma	5.69e-06	0.00048	CbGpPWpGaD
Nifedipine—CALM3—Immune System—HLA-DQB1—systemic scleroderma	5.69e-06	0.00048	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—CTGF—systemic scleroderma	5.58e-06	0.000471	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—HSPG2—systemic scleroderma	5.54e-06	0.000468	CbGpPWpGaD
Nifedipine—CALM2—Immune System—HLA-DQB1—systemic scleroderma	5.5e-06	0.000464	CbGpPWpGaD
Nifedipine—CALM1—Immune System—HLA-DQB1—systemic scleroderma	5.5e-06	0.000464	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—HSPG2—systemic scleroderma	5.5e-06	0.000464	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL1A—systemic scleroderma	5.4e-06	0.000456	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CD40LG—systemic scleroderma	5.37e-06	0.000453	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL1A—systemic scleroderma	5.23e-06	0.000441	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL1A—systemic scleroderma	5.23e-06	0.000441	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—NOS3—systemic scleroderma	5.21e-06	0.000439	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CD40LG—systemic scleroderma	5.2e-06	0.000439	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CD40LG—systemic scleroderma	5.2e-06	0.000439	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—CTGF—systemic scleroderma	5.12e-06	0.000432	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—HSPG2—systemic scleroderma	4.7e-06	0.000396	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—CTGF—systemic scleroderma	4.46e-06	0.000376	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CTGF—systemic scleroderma	4.2e-06	0.000355	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—TGFB1—systemic scleroderma	4.18e-06	0.000352	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CTGF—systemic scleroderma	4.16e-06	0.000351	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—CCL2—systemic scleroderma	4.07e-06	0.000343	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—TGFB1—systemic scleroderma	4.04e-06	0.000341	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—TGFB1—systemic scleroderma	4.04e-06	0.000341	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—CCL2—systemic scleroderma	3.93e-06	0.000332	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—CCL2—systemic scleroderma	3.93e-06	0.000332	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—HSPG2—systemic scleroderma	3.62e-06	0.000306	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CTGF—systemic scleroderma	3.56e-06	0.0003	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—NOS3—systemic scleroderma	3.56e-06	0.0003	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—EDN1—systemic scleroderma	3.51e-06	0.000297	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—EDN1—systemic scleroderma	3.4e-06	0.000287	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—EDN1—systemic scleroderma	3.4e-06	0.000287	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—NOS3—systemic scleroderma	3.26e-06	0.000275	CbGpPWpGaD
Nifedipine—CALM3—Disease—NOS3—systemic scleroderma	3.06e-06	0.000258	CbGpPWpGaD
Nifedipine—CALM2—Disease—NOS3—systemic scleroderma	2.96e-06	0.00025	CbGpPWpGaD
Nifedipine—CALM1—Disease—NOS3—systemic scleroderma	2.96e-06	0.00025	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL1B—systemic scleroderma	2.82e-06	0.000238	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CTGF—systemic scleroderma	2.75e-06	0.000232	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL1B—systemic scleroderma	2.73e-06	0.00023	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL1B—systemic scleroderma	2.73e-06	0.00023	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—NOS3—systemic scleroderma	2.63e-06	0.000222	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—NOS3—systemic scleroderma	2.58e-06	0.000217	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—NOS3—systemic scleroderma	2.57e-06	0.000217	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—NOS3—systemic scleroderma	2.56e-06	0.000216	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—NOS3—systemic scleroderma	2.48e-06	0.000209	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—NOS3—systemic scleroderma	2.48e-06	0.000209	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—NOS3—systemic scleroderma	2.43e-06	0.000205	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CCL2—systemic scleroderma	2.4e-06	0.000203	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CCL2—systemic scleroderma	2.32e-06	0.000196	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CCL2—systemic scleroderma	2.32e-06	0.000196	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—NOS3—systemic scleroderma	2.23e-06	0.000188	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NOS3—systemic scleroderma	2.14e-06	0.000181	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NOS3—systemic scleroderma	2.07e-06	0.000175	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NOS3—systemic scleroderma	2.07e-06	0.000175	CbGpPWpGaD
Nifedipine—CALM3—Disease—TGFB1—systemic scleroderma	2.02e-06	0.000171	CbGpPWpGaD
Nifedipine—CALM2—Disease—TGFB1—systemic scleroderma	1.96e-06	0.000165	CbGpPWpGaD
Nifedipine—CALM1—Disease—TGFB1—systemic scleroderma	1.96e-06	0.000165	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—NOS3—systemic scleroderma	1.94e-06	0.000164	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—NOS3—systemic scleroderma	1.83e-06	0.000154	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—NOS3—systemic scleroderma	1.81e-06	0.000153	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MMP9—systemic scleroderma	1.72e-06	0.000145	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MMP9—systemic scleroderma	1.66e-06	0.00014	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MMP9—systemic scleroderma	1.66e-06	0.00014	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—NOS3—systemic scleroderma	1.55e-06	0.000131	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TGFB1—systemic scleroderma	1.42e-06	0.000119	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TGFB1—systemic scleroderma	1.37e-06	0.000116	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TGFB1—systemic scleroderma	1.37e-06	0.000116	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—NOS3—systemic scleroderma	1.2e-06	0.000101	CbGpPWpGaD
